Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARL.L Regulatory News (ARL)

  • There is currently no data for ARL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

1 Oct 2007 08:53

Arlington Group Ltd01 October 2007 Arlington Group Limited (the "Company") Director's dealing Arlington Group Limited announces that, on 12 April 2007, Nicholas Barham,Chairman and CEO of the Company, acquired 20,000 ordinary shares of £0.005 eachin the Company at a price of 38 pence per ordinary share. This purchase raisedMr Barham's aggregate beneficial interest in the Company's equity to 45,301,429shares, representing 70.11% of the total voting rights. 1 October 2007 Enquiries: Arlington GroupColin HillOffice: +44 (0) 20 7389 5010 Evolution SecuritiesBobbie HilliamOffice: +44 (0)20 7071 4300 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Jun 200512:14 pmRNSHolding(s) in Company
24th May 20052:07 pmRNSHolding(s) in Company
18th Apr 20057:57 amRNSPut option exercise
18th Apr 20057:00 amRNSDisposal
30th Mar 200510:22 amRNSWarrant Agreement
23rd Feb 20053:39 pmRNSTransaction in Own Shares
26th Jan 200510:56 amRNSCancellation and re-admission
21st Jan 20051:16 pmRNSHolding(s) in Company
14th Jan 20053:32 pmRNSRule 8 - Prestbury Holdings
13th Jan 20052:03 pmRNSScheme of arrangement
6th Jan 20059:33 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.